Explore the words cloud of the ImPRESS project. It provides you a very rough idea of what is the project "ImPRESS" about.
The following table provides information about the project.
OSLO UNIVERSITETSSYKEHUS HF
|Coordinator Country||Norway [NO]|
|Total cost||1˙499˙638 €|
|EC max contribution||1˙499˙638 € (100%)|
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
|Duration (year-month-day)||from 2018-01-01 to 2022-12-31|
Take a look of project's partnership.
|1||OSLO UNIVERSITETSSYKEHUS HF||NO (OSLO)||coordinator||1˙499˙638.00|
Even the perfect cancer drug must reach its target to have an effect. The ImPRESS project main objective is to develop a novel imaging paradigm coined Restricted Perfusion Imaging (RPI) to reveal - for the first time in humans - vascular restrictions in solid cancers caused by mechanical solid stress, and use RPI to demonstrate that alleviating this force will repair the cancerous microenvironment and improve therapeutic response. Delivery of anti-cancer drugs to the tumor is critically dependent on a functional vascular bed. Developing biomarkers that can measure how mechanical forces in a solid tumor impair perfusion and promotes therapy resistance is essential for treatment of disease.
The ImPRESS project is based on the following observations; (I) pre-clinical work suggests that therapies targeting the tumor microenvironment and extracellular matrix may enhance drug delivery by decompressing tumor vessels; (II) results from animal models may not be transferable because compressive forces in human tumors in vivo can be many times higher; and (III) there are no available imaging technologies for medical diagnostics of solid stress in human cancers. Using RPI, ImPRESS will conduct a comprehensive series of innovative studies in brain cancer patients to answer three key questions: (Q1) Can we image vascular restrictions in human cancers and map how the vasculature changes with tumor growth or treatment? (Q2) Can we use medical engineering to image solid stress in vivo? (Q3) Can RPI show that matrix-depleting drugs improve patient response to conventional chemo- and radiation therapy as well as new targeted therapies?
The ImPRESS project holds a unique position to answer these questions by our unrivaled experience with advanced imaging of cancer patients. With successful delivery, ImPRESS will have a direct impact on patient treatment and establish an imaging paradigm that will pave the way for new scientific knowledge on how to revitalize cancer therapies.
|year||authors and title||journal||last update|
Stelios Angeli, Kyrre E. Emblem, Paulina Due-Tonnessen, Triantafyllos Stylianopoulos
Towards patient-specific modeling of brain tumor growth and formation of secondary nodes guided by DTI-MRI
published pages: 664-673, ISSN: 2213-1582, DOI: 10.1016/j.nicl.2018.08.032
|NeuroImage: Clinical 20||2020-01-21|
Ingrid Digernes, Endre GrÃ¸vik, Line B. Nilsen, Cathrine Saxhaug, Oliver Geier, Edmund Reitan, Dag Ottar SÃ¦tre, Birger Breivik, Timothy Reese, Kari Dolven Jacobsen, Ã…slaug Helland, Kyrre Eeg Emblem
Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
published pages: 559-567, ISSN: 2452-1094, DOI: 10.1016/j.adro.2018.05.005
|Advances in Radiation Oncology 3/4||2020-01-21|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMPRESS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "IMPRESS" are provided by the European Opendata Portal: CORDIS opendata.
Dynamic Modeling of Labor Market Mobility and Human Capital AccumulationRead More
VIrTual BrAin PErfusion: Assessing cerebrovascular function by High Performance Computing from 3D brain vessel network data for vascular-targeted drug development in neurodegenerative diseases.Read More
The Memory of SolitonsRead More